PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Tenecteplase - Stroke/TIA
PAD Profile : Tenecteplase - Stroke/TIA
Keywords :
acute ischaemic stroke
Brand Names Include :
Metalyse
Traffic Light Status
Status 1 of 1.
Status :
Red
Formulations :
- Injection
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Type
Document
Review Date
Guidelines
No guidelines returned.
Other Drugs
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
07 August 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Area Prescribing Committee recommends the use of tenecteplase for the treatment of acute ischaemic stroke in line with NICE TA990.
Tenecteplase will be considered as RED on the traffic light system.
Associated BNF Codes
02. Cardiovascular System
02.10.02. Fibrinolytic drugs